Key Takeaways
- Cantata Health Solutions launches Arize MAT, an integrated tool for methadone and buprenorphine treatment.
- The platform aims to enhance care delivery for individuals with opioid use disorder (OUD) through streamlined dispensing and compliance features.
- Partnership with Zero Overdose strengthens support for overdose prevention and community education.
Cantata Health Solutions has introduced Arize MAT, a Medication-Assisted Treatment module designed to support professionals caring for individuals with opioid use disorder (OUD). This innovative tool integrates seamlessly with their behavioral health EHR platform, facilitating methadone and buprenorphine treatment amid societal and regulatory challenges.
Arize MAT addresses the complex needs of patients by streamlining the dispensing process and improving treatment visibility. It encompasses a variety of features that assist in audits by regulatory bodies such as the Drug Enforcement Administration (DEA) and the Joint Commission.
Christy Winter, Vice President of Product Management at Cantata Health Solutions, emphasized the importance of an integrated platform in fostering personalized MAT approaches. She noted that working with a single vendor can enhance operational efficiency and elevate care quality, which is crucial in this evolving sector.
Alan Tillinghast, CEO of Cantata Health Solutions, highlighted the significance of a comprehensive approach. He explained that unlike many EHR systems that rely on third-party partnerships or disjointed add-ons, Arize MAT provides a fully integrated solution. This not only reduces dispensing time and costs but also improves the overall healthcare experience for patients.
Key features of Arize MAT include:
- Streamlined Dispensing: Automates dispensing schedules for both clinic-based and take-home doses, alongside toxicology management.
- Patient Engagement: Offers secure portals and appointment reminders to foster adherence.
- Data Security: Incorporates consent management tools compliant with 42 CFR Part 2 to protect sensitive information.
- Addressing Social Determinants: Tracks social drivers of health and facilitates referrals to vital services.
- Analytics for Improvement: Provides equity and outcomes dashboards for continuous quality enhancement.
In collaboration with Zero Overdose, Arize MAT incorporates overdose risk screenings and safety planning tools, further equipping providers to offer comprehensive support to individuals facing the risk of overdose. Virna Little, co-founder of Zero Overdose, affirmed their mutual commitment to delivering equitable, evidence-based care for people with OUD.
For more information about Arize MAT, visit Cantata Health Solutions.
The content above is a summary. For more details, see the source article.
